Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
κ-opioid receptor - Wikipedia
Nephrology Journal Club on X: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
Mu Agonist Opioids and Kappa Opioids | Download Table
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Molecules | Free Full-Text | Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Kappa Receptors – Opioid Peptides
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role | Semantic Scholar
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
The Kappa Opioid Receptor | SpringerLink
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
